Alkem Laboratories Ltd
NSE:ALKEM

Watchlist Manager
Alkem Laboratories Ltd Logo
Alkem Laboratories Ltd
NSE:ALKEM
Watchlist
Price: 5 713 INR -0.17% Market Closed
Market Cap: 683B INR

Operating Margin
Alkem Laboratories Ltd

17.1%
Current
15%
Average
6.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
17.1%
=
Operating Profit
22.8B
/
Revenue
133B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
IN
Alkem Laboratories Ltd
NSE:ALKEM
683.1B INR
17%
US
Eli Lilly and Co
NYSE:LLY
971B USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
479.2B USD
27%
CH
Roche Holding AG
SIX:ROG
245.2B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
24%
CH
Novartis AG
SIX:NOVN
195.9B CHF
33%
US
Merck & Co Inc
NYSE:MRK
240.1B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
202B USD
11%
US
Pfizer Inc
NYSE:PFE
142.9B USD
29%
No Stocks Found

Alkem Laboratories Ltd
Glance View

Alkem Laboratories Ltd., founded in 1973, has emerged as a significant player in India's pharmaceutical landscape, deftly combining innovation with a robust distribution network. Anchored in Mumbai, Alkem began as a modest venture but quickly evolved into a powerhouse, renowned for manufacturing a broad spectrum of branded generics, over-the-counter products, and active pharmaceutical ingredients (APIs). The company's success lies in its ability to cater to both domestic and international markets, primarily thriving on the ever-increasing demand for affordable healthcare solutions. Its formidable market presence in India is supported by a strong sales force and an extensive distribution network, ensuring its therapies reach even the most remote corners of the country. Internationally, Alkem has carved a niche for itself, with the United States being one of its major export markets. It strategically entered this competitive arena, building a portfolio of ANDAs (Abbreviated New Drug Applications) that allowed it to provide lower-cost alternatives to big pharma's patented drugs. This not only fueled its revenue growth but also fortified its standing as a go-to source for quality generics. Alkem's research and development efforts underpin its commitment to healthcare innovation, as it constantly seeks to expand its therapeutic repertoire. By consistently focusing on quality, affordability, and resourceful adaptation to global healthcare needs, Alkem Laboratories Ltd. has managed to script a growth story that is both impressive and sustainable.

ALKEM Intrinsic Value
4 601.8 INR
Overvaluation 19%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
17.1%
=
Operating Profit
22.8B
/
Revenue
133B
What is the Operating Margin of Alkem Laboratories Ltd?

Based on Alkem Laboratories Ltd's most recent financial statements, the company has Operating Margin of 17.1%.

Back to Top